Development
Cytokinetics, Incorporated
CYTK
$35.14
-$1.02-2.82%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.02% | -4.68% | -14.80% | -15.16% | -9.81% |
| Total Receivables | -48.66% | 153.71% | -2.09% | 584.35% | -93.59% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -39.30% | 0.95% | 38.63% | 12.83% | -12.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -76.56% | -- | -- |
| Total Current Assets | 11.87% | -4.29% | -13.82% | -14.41% | -10.07% |
|
|
|||||
| Total Current Assets | 11.87% | -4.29% | -13.82% | -14.41% | -10.07% |
| Net Property, Plant & Equipment | -5.02% | -1.63% | -1.59% | -1.55% | 5.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -2.33% | -1.82% | 2.71% | -16.22% | 24.82% |
| Total Assets | 11.30% | -5.04% | -12.35% | -12.31% | -5.69% |
|
|
|||||
| Total Accounts Payable | 55.89% | 9.83% | -27.63% | -32.23% | 77.50% |
| Total Accrued Expenses | 29.40% | 4.72% | -11.68% | -19.19% | 9.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 68.08% | 9.78% | 10.08% | 3.45% | -19.17% |
| Total Finance Division Other Current Liabilities | -30.41% | 133.42% | -26.14% | 609.53% | -76.52% |
| Total Other Current Liabilities | -30.41% | 133.42% | -26.14% | 609.53% | -76.52% |
| Total Current Liabilities | 32.11% | 18.45% | -12.77% | -11.11% | 10.62% |
|
|
|||||
| Total Current Liabilities | 32.11% | 18.45% | -12.77% | -11.11% | 10.62% |
| Long-Term Debt | -0.27% | -0.12% | -0.14% | 0.16% | 0.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.68% | -1.47% | -1.37% | -0.57% | 9.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.69% | 18.16% | 2.07% | 1.75% | 3.52% |
| Total Liabilities | 2.65% | 5.97% | -0.52% | -0.34% | 2.81% |
|
|
|||||
| Common Stock & APIC | 12.26% | 1.53% | 1.63% | 0.56% | 3.02% |
| Retained Earnings | -6.93% | -7.01% | -7.49% | -8.28% | -9.48% |
| Treasury Stock & Other | 98.86% | 40.05% | 11.37% | 54.18% | 35.42% |
| Total Common Equity | 11.96% | -31.73% | -45.45% | -112.25% | -575.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.96% | -31.73% | -45.45% | -112.25% | -575.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.96% | -31.73% | -45.45% | -112.25% | -575.35% |
|
|
|||||